LONDON BROKER RATINGS: Experian on JPMorgan focus list at 'overweight'
(Alliance News) - The following London-listed shares received analyst recommendations on Thursday morning and on Wednesday: Read More
| Price | 361.80p on 20-02-2026 at 19:40:05 |
|---|---|
| Change | 0.60p 0.17% |
| Buy | 362.80p |
| Sell | 362.20p |
| Last Trade: | Buy 4,674.00 at 363.586p |
| Day's Volume: | 503,823 |
| Last Close: | 361.80p |
| Open: | 364.00p |
| ISIN: | GB00BM8NFJ84 |
| Day's Range | 361.00p - 367.60p |
| 52wk Range: | 300.00p - 501.00p |
| Market Capitalisation: | £1.25b |
| VWAP: | 363.0117p |
| Shares in Issue: | 346.68m |
Breedon (BREE) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 4,674 | 363.586p | SI Trade Negotiated Trade |
16:47:07 - 20-Feb-26 |
| Buy* | 233,187 | 361.80p | Suspected BUY Trade |
16:35:06 - 20-Feb-26 |
| Sell* | 5 | 362.20p | Automatic Execution |
16:29:50 - 20-Feb-26 |
| Sell* | 108 | 362.20p | Automatic Execution |
16:29:50 - 20-Feb-26 |
| Sell* | 44 | 362.20p | Automatic Execution |
16:29:41 - 20-Feb-26 |
| Sell* | 100 | 362.20p | Automatic Execution |
16:29:41 - 20-Feb-26 |
| Sell* | 8 | 362.20p | Automatic Execution |
16:29:41 - 20-Feb-26 |
| Buy* | 5 | 363.20p | SI Trade |
16:29:36 - 20-Feb-26 |
| Sell* | 100 | 362.40p | Automatic Execution |
16:29:36 - 20-Feb-26 |
| Sell* | 310 | 362.40p | Automatic Execution |
16:29:36 - 20-Feb-26 |
Breedon (BREE) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th Feb 2026 4:01 pm | RNS | Issue of Shares |
| 30th Jan 2026 12:44 pm | RNS | Block Listing Update |
| 30th Jan 2026 7:00 am | RNS | Notice of Annual Results 2025 |
| 31st Dec 2025 7:00 am | RNS | BLOCK LISTING SIX MONTHLY RETURN |
| 31st Dec 2025 7:00 am | RNS | Total Voting Rights |
| 2nd Dec 2025 3:49 pm | RNS | Director/PDMR Shareholding |
| 28th Nov 2025 3:29 pm | RNS | Director/PDMR Shareholding |
| 28th Nov 2025 8:55 am | RNS | Total Voting Rights |
| 26th Nov 2025 5:20 pm | RNS | Director/PDMR Shareholding |
| 21st Nov 2025 7:00 am | RNS | Director/PDMR Shareholding |